Navigation Links
Emerging Markets for Diagnostic Imaging Systems Hurt by Economic Crisis
Date:4/23/2009

Revenues from CT and MRI scanner sales in Russia, Brazil, and India will shrink by almost 15% in 2009, according to Millennium Research Group

WALTHAM, Mass., April 23 /PRNewswire/ -- According to Millennium Research Group's (MRG's) report series covering the diagnostic imaging markets in Brazil, India, and Russia, the global economic crisis will severely limit growth in the diagnostic imaging markets in these 3 countries in 2009, particularly for advanced computed tomography (CT) and magnetic resonance imaging (MRI) imaging modalities. Combined revenues from CT and MRI scanner sales in Brazil, India, and Russia will shrink by almost 15% in 2009.

The current economic downturn has resulted in a significant devaluation of both the Brazilian and Indian currencies over the first four months of 2009. This, in turn, has increased the relative cost of imported diagnostic imaging systems from the US and Europe. This higher pricing has made acquiring imported scanners difficult for facilities, and as a result, growth in the Brazilian and Indian diagnostic imaging system market will be severely limited in 2009. In Russia, the impact of economic uncertainty has been compounded by political unrest.

"Reduced prices for crude oil -- Russia's chief export -- led to less health care funding and curbed spending," says Ravindra Sharma, Senior Analyst at MRG. "Although diagnostic imaging systems will still sell during this time, many facilities are expected to opt for less expensive lower-end systems, leading to an overall decline in revenues in 2009."

MRG's Emerging Markets for Diagnostic Imaging 2009 report series -- which covers China in addition to Brazil, India, and Russia -- provides competitive analysis of key industry players, including Agfa HealthCare, FUJIFILM Medical Systems, GE Healthcare, Hitachi Medical Systems, MEDISON, Mindray Medical International, Philips Healthcare, Siemens Healthcare, SonoSite, Toshiba Medical Systems, as well as a number of domestic competitors.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through syndicated reports, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina)
2. For Erectile Dysfunction, Physicians Indicate That Opportunity Exists for Emerging Therapies with Improved Efficacy in Difficult-to-Treat Patient Subpopulations
3. Starkey Hearing Foundation Partners With GRAMMY Foundation(R) to Announce SoundMatters(TM) Initiative: GRAMMY-Nominated Artist Taylor Swift, Along With Emerging Artists Crosby Loggins, Jimmy Wayne and GRAMMY-Nominated Sara Bareilles Lead the Way in the Pr
4. Manhattan Research: Physician New Media Adoption in Emerging Pharma Markets - Webcast April 3
5. VNUS Medical Technologies to Present at the Sidoti & Company 13th Annual New York Emerging Growth Institutional Investor Forum
6. HMS Holdings Corp. to Present at the Sidoti & Co. 13th Annual New York Emerging Growth Institutional Investor Forum
7. Cantel Medical Corp. to Present at the 13th Annual Sidoti & Company Emerging Growth Institutional Investor Forum
8. Abaxis, Inc. to Present at Sidoti & Companys Thirteenth Annual New York Emerging Growth Institutional Investor Forum
9. Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
10. Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017
11. Drug blocks two of worlds deadliest emerging viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: